Dec 15, 2022 / 07:00PM GMT
Allison Soss - KCSA Strategic Communications - SVP
Hello, and welcome to the KCSA Mental Health Virtual Investor Conference. My name is Allison Soss, and on behalf of KCSA Strategic Communications, as well as our co-host, the OTC Markets Group, we're very pleased you have joined us for our next live presentation from Tryp Therapeutics.
(Operator Instructions) On a final note, all today's presentations will be recorded and available for 24/7 replay. At this point, I'm very pleased to welcome Jim Gilligan, Interim CEO, President, and Chief Scientific Officer of Tryp Therapeutics, which trades on the OTCQB Venture Market under the symbol TRYPF, and on the CSE under the symbol TRYP. Welcome, Jim.
Jim Gilligan - Tryp Therapeutics, Inc. - CEO, President & Chief Scientific Officer
Thank you, Allison. I'd like to thank the organization for providing the opportunity to introduce Tryp Therapeutics to those not familiar with Tryp, as well as an opportunity to update what we've accomplished over the last few months for those who've been following the company.
TRYP Therapeutics Inc at OTC Markets KCSA Mental Health Investor Conference Transcript
Dec 16, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers